title: Re: The Impact of Bleomycin on Retroperitoneal Histology at Post-Chemotherapy Retroperitoneal Lymph Node Dissection of Good Risk Germ Cell Tumors: K. C. Cary, J. A. Pedrosa, H. Z. Kaimakliotis, T. A. Masterson, L. H. Einhorn and R. S. Foster J Urol 2015;193:507-512.
authors: Department of Urology, Sawai Man Singh Medical College and Hospital, Jaipur, Rajasthan, India.
authors: Amit
authors: A
authors: Verma
authors: Department of Urology, Sawai Man Singh Medical College and Hospital, Jaipur, Rajasthan, India.
authors: Vikas
authors: V
authors: Giri
authors: Department of Urology, Sawai Man Singh Medical College and Hospital, Jaipur, Rajasthan, India.
authors: Shivam
authors: S
authors: Priyadarshi
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use*; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy* / Q000601:surgery*; D012187:Retroperitoneal Space / Q000473:pathology*; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000601:surgery*
chemical_list: D000903:Antibiotics, Antineoplastic; D001761:Bleomycin